AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 3
Authors: KASSOTIS J COSTEAS C BLITZER M REIFFEL JA
Citation: J. Kassotis et al., RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 3, PACE, 21(5), 1998, pp. 1133-1145
RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 2
Authors: COSTEAS C KASSOTIS J BLITZER M REIFFEL JA
Citation: C. Costeas et al., RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 2, PACE, 21(4), 1998, pp. 742-752
RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 1
Authors: BLITZER M COSTEAS C KASSOTIS J REIFFEL JA
Citation: M. Blitzer et al., RHYTHM MANAGEMENT IN ATRIAL-FIBRILLATION - WITH A PRIMARY EMPHASIS ONPHARMACOLOGICAL THERAPY - PART 1, PACE, 21(3), 1998, pp. 590-602
BETA-BLOCKER USE AND MORTALITY IN THE ANTIARRHYTHMICS VERSUS IMPLANTABLE DEFIBRILLATORS (AVID) COHORT
Authors: EXNER DV EPSTEIN AE REITER MJ YAO Q LEDINGHAM R REIFFEL JA BRODSKY M AKIYAMA T SCHRON E FOLLMANN D ANDERSON J
Citation: Dv. Exner et al., BETA-BLOCKER USE AND MORTALITY IN THE ANTIARRHYTHMICS VERSUS IMPLANTABLE DEFIBRILLATORS (AVID) COHORT, Circulation, 98(17), 1998, pp. 2598-2598
A SYMPOSIUM - ATRIAL-FIBRILLATION - MECHANISM AND MANAGEMENT - INTRODUCTION
Authors: REIFFEL JA CAMM J
Citation: Ja. Reiffel et J. Camm, A SYMPOSIUM - ATRIAL-FIBRILLATION - MECHANISM AND MANAGEMENT - INTRODUCTION, The American journal of cardiology, 82, 1998, pp. 1-1
EPIDEMIOLOGY AND INCIDENCE OF ATRIAL-FIBRILLATION - DISCUSSION
Authors: PRITCHETT E KANNEL WB REIFFEL JA OLSHANSKY B LUDERITZ B REITER M FALK RH CAMM J
Citation: E. Pritchett et al., EPIDEMIOLOGY AND INCIDENCE OF ATRIAL-FIBRILLATION - DISCUSSION, The American journal of cardiology, 82, 1998, pp. 8-9
ATRIAL-FIBRILLATION - ETIOLOGY, HISTOLOGY AND RISK-FACTORS - DISCUSSION
Authors: SUNG R FALK RH CAMM J REIFFEL JA KERR CR WALDO A WHARTON M KAUFMAN E
Citation: R. Sung et al., ATRIAL-FIBRILLATION - ETIOLOGY, HISTOLOGY AND RISK-FACTORS - DISCUSSION, The American journal of cardiology, 82, 1998, pp. 16-17
ANTICOAGULATION IN ATRIAL-FIBRILLATION PATIENTS - DISCUSSION
Authors: WALDO A NADEMANEE K KOWEY PR REIFFEL JA FALK RH
Citation: A. Waldo et al., ANTICOAGULATION IN ATRIAL-FIBRILLATION PATIENTS - DISCUSSION, The American journal of cardiology, 82, 1998, pp. 41-42
ELECTROPHYSIOLOGY OF ANTIARRHYTHMIC DRUGS FOR ATRIAL-FIBRILLATION - DISCUSSION
Authors: SUNG R GRANT AO FELD G REITER M FRIEDMAN PL REIFFEL JA KERR CR CAMM J
Citation: R. Sung et al., ELECTROPHYSIOLOGY OF ANTIARRHYTHMIC DRUGS FOR ATRIAL-FIBRILLATION - DISCUSSION, The American journal of cardiology, 82, 1998, pp. 48-49
METAANALYSIS OF THE EFFICACY OF PROPAFENONE FOR TREATING SUPRAVENTRICULAR ARRHYTHMIAS - DISCUSSION
Authors: REIFFEL JA REIMOLD SC
Citation: Ja. Reiffel et Sc. Reimold, METAANALYSIS OF THE EFFICACY OF PROPAFENONE FOR TREATING SUPRAVENTRICULAR ARRHYTHMIAS - DISCUSSION, The American journal of cardiology, 82, 1998, pp. 71-71
SELECTING AN ANTIARRHYTHMIC AGENT FOR ATRIAL-FIBRILLATION SHOULD BE APATIENT-SPECIFIC, DATA-DRIVEN DECISION
Authors: REIFFEL JA
Citation: Ja. Reiffel, SELECTING AN ANTIARRHYTHMIC AGENT FOR ATRIAL-FIBRILLATION SHOULD BE APATIENT-SPECIFIC, DATA-DRIVEN DECISION, The American journal of cardiology, 82, 1998, pp. 72-80
DATA-DRIVEN DECISIONS - PICKING THE CORRECT AGENT - DISCUSSION
Authors: GRANT AO REIFFEL JA WINTERS S PAGE R WEBB C KUTALEK S NADEMANEE K OLSHANSKY B CARLSON M FERRICK K
Citation: Ao. Grant et al., DATA-DRIVEN DECISIONS - PICKING THE CORRECT AGENT - DISCUSSION, The American journal of cardiology, 82, 1998, pp. 80-81
IMPORTANCE OF BETA-BLOCKADE IN THE THERAPY OF SERIOUS VENTRICULAR ARRHYTHMIAS
Authors: REITER MJ REIFFEL JA
Citation: Mj. Reiter et Ja. Reiffel, IMPORTANCE OF BETA-BLOCKADE IN THE THERAPY OF SERIOUS VENTRICULAR ARRHYTHMIAS, The American journal of cardiology, 82(4A), 1998, pp. 9-19
ANTIARRHYTHMIC DRUGS AND DEVICES FOR THE MANAGEMENT OF VENTRICULAR TACHYARRHYTHMIA IN ISCHEMIC-HEART-DISEASE
Authors: REIFFEL JA REITER MJ BLITZER M
Citation: Ja. Reiffel et al., ANTIARRHYTHMIC DRUGS AND DEVICES FOR THE MANAGEMENT OF VENTRICULAR TACHYARRHYTHMIA IN ISCHEMIC-HEART-DISEASE, The American journal of cardiology, 82(4A), 1998, pp. 31-40
IMPACT OF STRUCTURAL HEART-DISEASE ON THE SELECTION OF CLASS-III ANTIARRHYTHMICS FOR THE PREVENTION OF ATRIAL-FIBRILLATION AND FLUTTER
Authors: REIFFEL JA
Citation: Ja. Reiffel, IMPACT OF STRUCTURAL HEART-DISEASE ON THE SELECTION OF CLASS-III ANTIARRHYTHMICS FOR THE PREVENTION OF ATRIAL-FIBRILLATION AND FLUTTER, The American heart journal, 135(4), 1998, pp. 551-556
IS PROCAINAMIDE FAILURE AT ELECTROPHYSIOLOGIC TESTING REALLY AN APPROPRIATE MARKER FOR DRUG-RESISTANT VENTRICULAR TACHYARRHYTHMIAS
Authors: REIFFEL JA HAHN E HARTZ V
Citation: Ja. Reiffel et al., IS PROCAINAMIDE FAILURE AT ELECTROPHYSIOLOGIC TESTING REALLY AN APPROPRIATE MARKER FOR DRUG-RESISTANT VENTRICULAR TACHYARRHYTHMIAS, Journal of the American College of Cardiology, 29(2), 1997, pp. 14129-14129
PROLONGING SURVIVAL BY REDUCING ARRHYTHMIC DEATH - PHARMACOLOGICAL THERAPY OF VENTRICULAR-TACHYCARDIA AND FIBRILLATION
Authors: REIFFEL JA
Citation: Ja. Reiffel, PROLONGING SURVIVAL BY REDUCING ARRHYTHMIC DEATH - PHARMACOLOGICAL THERAPY OF VENTRICULAR-TACHYCARDIA AND FIBRILLATION, The American journal of cardiology, 80, 1997, pp. 45-55
INFLUENCE OF PATIENT CHARACTERISTICS IN THE SELECTION OF PATIENTS FORDEFIBRILLATOR IMPLANTATION (THE AVID REGISTRY)
Authors: CURTIS AB HALLSTROM AP KLEIN RC NATH S PINSKI SL EPSTEIN AE WYSE DG CANNOM DS RENFROE E COOPER AS DAILEY SM KAY GN PLUMB VJ BUBIEN RS KNOTTS SM MCKENNA PT GREER GS SANTORO IH SWAIM J WHITTLE S BELCO KM PAYNE JP ARNOLD DJ ZHU WX PRATT CM COOK JR KABELL G KIRCHHOFFER JB WARWICK D BURKOTT B TOMASZEWSKI D PODRID PJ FUCHS TT MAZUR M FRIEDMAN PL STEVENSON WG SWAT MM GANZ LL SWEENEY MO SHEA JB BRODSKY MA ALLEN BJ EHRLICH SS WOLFF LJ MACARIHINSON MM SCHEINMAN M EISENBERG S EPSTEIN L FITZPATRICK A GRIFFIN G LEE R LESH M WONG MN WONG M WILKOFF BL CROSS JA SHEWCHIK JM CARLSON MD ROSENBAUM DS LEWIS WR BIBLO LA MACKALL JA WALDO AL COROMILAS J BIGGER JT LIVELLI FD REIFFEL JA HICKEY K BERNS E LIPPMAN N BARRY MB CARNEY HM RUSSO AM WAXMAN HL STUBIN CA MORRISSEY JM RASPA DH CHILSON DA LESSMEIER TJ POCHIS WT BAXTER JM NADEMANEE K WEINBERGER J BAILEY W REITER M SAKSENA S KROL RB MUNSIF AN LEWIS CA LUCERI RM ZILO P WEISS DN JONAS A VARDEMAN L SCHWARTZ KM CURTIS AB CONTI JB NELSON C BHANDARI AK LERMAN RD FIRTH BR ZIPES DP ENGELSTEIN ED MILES WM FOREMAN L MARTINS JB LEE HC HOPSON JR HOPSON R MARINCHAK RA RIALS SJ KOWEY PR FILART RA HERNANDEZ M SCHER DL ZUKERMAN LS FARRELL S KOLK D CRINER H TAIT B KUTALEK SP HESSEN SE MOVSOWITZ C SAMUELS F WILBER S BAESSLER C SOTO D SCHUSTER M SCOTT G COVELASKYROBINSON R FLETCHER S FINN LS SAARI C TORRES VI PAL S PLATT ML TIMOTHY PCR BISHOP VL LOVE JC CUTLER JE BOSWORTHFARRELL S GOLD MR SHOROFSKY S PETERS R KAVESH N FROMAN D SCOTT H ROTH JA GADHOKE AM MAUERMANN SK PACIFICO A NASIR N TRAINOR K FOSTER P CREVEY B GENOVELY H SCHUTZMAN J VIATER K COYLE C NORA MO OTOOLE MF COLLURA R ENGER EL ALMQUIST A BALDWIN P HAUSER R MILSTEIN S PRITZKER M SCHREIBER V KIM SG FISHER JD FERRICK KJ GROSS JN BENZUR U DURKIN J FERRICK A ZEBEDE J SAMET P TOLENTINO AO RUBIN S HERRE JM BERNSTEIN RC KLEVAN LR JADONATH RL GOLDNER B MERKATZ K CHEPURKO L BECKMAN KJ MCCLELLAND JH GONZALEZ MD WIDMAN LE LANE R MCANULTY JH HALPERIN BD KRON J LARSEN GC RAITT MH SWENSON RD FLOREK RC MARCHANT C HAMLIN M HEYWOOD G DAUBERT JP KIM C SWITZER D PANDE P FLYNN D KELLER M OCAMPO CM WAHL K VOGT J TULLO NG IRMIERE CA HENRY A STEINBERG JS EHLERT F ZELENKOFSKE S MENCHAVEZTAN E DESTEFANO M BROWN G SUNG RJ LIEM LB YOUNG C LAUER MR PETERSON J OTTOBONI L GOOLD P ROME M KRESGE K BUXTON AE HSIA HH MILLER JM ROTHMAN SA ADELIZZI N GASTINEAU ME THOME LM WHITLEY DM SHIH HT DOUGHERTY AH JALAL S NACCARRELLI GV WOLBRETTE D WILSON D PAGE RL JESSEN M CANBY RC ERWIN G ANDERSON JL CRANDALL BG KARAGOUNIS LA OSBORN JS RAWLING DA SUMMERS K BIGGINS M FREEDMAN R MARKS M CHIEN W STEVENOT R MERILLAT J MCPHERSON M ECHT DS RODEN DM WATHEN MS LEE JT MURRAY KT BAKER JH CRAWFORD DM HAINES D ACKERMAN S BOWMAN L STAMATO NJ WHITING D JENKINS LS CONNOLLY S HALLSTROM AP GREENE HL YAO Q SCHOLZ M POWELL JL RENFROE EG SULLIVAN S LEDINGHAM RB MORRIS MF LANCASTER SE MOORE R OLARTE A SCHRON EB DOMANSKI MJ FOLLMANN D ROSENBERG Y JENNINGS CA
Citation: Ab. Curtis et al., INFLUENCE OF PATIENT CHARACTERISTICS IN THE SELECTION OF PATIENTS FORDEFIBRILLATOR IMPLANTATION (THE AVID REGISTRY), The American journal of cardiology, 79(9), 1997, pp. 1185-1189
SOTALOL FOR VENTRICULAR TACHYARRHYTHMIAS - BETA-BLOCKING AND CLASS-III CONTRIBUTIONS, AND RELATIVE EFFICACY VERSUS CLASS-I DRUGS AFTER PRIOR DRUG FAILURE
Authors: REIFFEL JA HAHN E HARTZ V REITER MJ
Citation: Ja. Reiffel et al., SOTALOL FOR VENTRICULAR TACHYARRHYTHMIAS - BETA-BLOCKING AND CLASS-III CONTRIBUTIONS, AND RELATIVE EFFICACY VERSUS CLASS-I DRUGS AFTER PRIOR DRUG FAILURE, The American journal of cardiology, 79(8), 1997, pp. 1048-1053
REPRODUCIBILITY OF DRUG EFFICACY PREDICTIONS BY HOLTER MONITORING IN THE ELECTROPHYSIOLOGIC STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING (ESVEM) TRIAL
Authors: REITER MJ KARAGOUNIS LA MANN DE REIFFEL JA HAHN E HARTZ V
Citation: Mj. Reiter et al., REPRODUCIBILITY OF DRUG EFFICACY PREDICTIONS BY HOLTER MONITORING IN THE ELECTROPHYSIOLOGIC STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING (ESVEM) TRIAL, The American journal of cardiology, 79(3), 1997, pp. 315-322
A SUMMARY AND ASSESSMENT OF THE FINDINGS AND CONCLUSIONS OF THE ESVEMTRIAL
Authors: MASON JW MARCUS FI BIGGER JT LAZZARA R REIFFEL JA REITER MJ MANN D
Citation: Jw. Mason et al., A SUMMARY AND ASSESSMENT OF THE FINDINGS AND CONCLUSIONS OF THE ESVEMTRIAL, Progress in cardiovascular diseases, 38(5), 1996, pp. 347-358
INFLUENCE OF HOLTER MONITOR AND ELECTROPHYSIOLOGIC STUDY METHODS AND EFFICACY CRITERIA ON THE OUTCOME OF PATIENTS WITH VENTRICULAR-TACHYCARDIA AND VENTRICULAR-FIBRILLATION IN THE ESVEM TRIAL
Authors: REIFFEL JA REITER MJ FREEDMAN RA MANN D HUANG SKS HAHN E HARTZ V MASON J MARCUS FI CARUSO A FAITELSON HL RAYA TE GARCIA Z GEAR K PIERCE MK PRATT CM BOAHENE A PACIFICO A WYNDHAM C FRANCIS M KERR CR YEUNG JA VORDERBRUGGE S GRIFFIN JC LESH M SCHEINMAN MM WONG M WONG M HEYBORNE T KENNY C BIGGER JT LIVELLI FD STEINBERG JS CAMPION J SQUATRITO AM MITTLEMAN R COLLETTWILLEY P ROFINO K SAKSENA S KROL RB DUQUE L KLEIN RC MACHELL C WIDMAN ML ACOSTAMILLER C LOMELI G KEHOE R ZHEUTLIN TA MATTIONI T DUNNINGTON C LAZZARA R BECKMAN K FRIDAY K JACKMAN WM DEATON T DRENNAN K FOSTER J HARRIS S MCANULTY JH KRON J HALPERIN BD SINNER K MARTIN K HOROWITZ LN GOTTLIEB CD VRABEL C MASON JW ANDERSON JL ANDERSON KP KARAGOUNIS L RAWLING DA HUTSON H MANNIS D ROSKELLEY M MOON T RICO A JENROW N BRESSLER R GREENE HL LEBOWITZ M MORKIN E WEAVER WD BUMP T MORADY F OLSHANSKY B
Citation: Ja. Reiffel et al., INFLUENCE OF HOLTER MONITOR AND ELECTROPHYSIOLOGIC STUDY METHODS AND EFFICACY CRITERIA ON THE OUTCOME OF PATIENTS WITH VENTRICULAR-TACHYCARDIA AND VENTRICULAR-FIBRILLATION IN THE ESVEM TRIAL, Progress in cardiovascular diseases, 38(5), 1996, pp. 359-370
EXPLORATION OF THE PRECISION OF CLASSIFYING SUDDEN CARDIAC DEATH - IMPLICATIONS FOR THE INTERPRETATION OF CLINICAL-TRIALS
Authors: PRATT CM GREENWAY PS SCHOENFELD MH HIBBEN ML REIFFEL JA
Citation: Cm. Pratt et al., EXPLORATION OF THE PRECISION OF CLASSIFYING SUDDEN CARDIAC DEATH - IMPLICATIONS FOR THE INTERPRETATION OF CLINICAL-TRIALS, Circulation, 93(3), 1996, pp. 519-524
IMPLICATIONS OF THE ELECTROPHYSIOLOGIC STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING TRIAL FOR CONTROLLING VENTRICULAR-TACHYCARDIA AND FIBRILLATION
Authors: REIFFEL JA
Citation: Ja. Reiffel, IMPLICATIONS OF THE ELECTROPHYSIOLOGIC STUDY VERSUS ELECTROCARDIOGRAPHIC MONITORING TRIAL FOR CONTROLLING VENTRICULAR-TACHYCARDIA AND FIBRILLATION, The American journal of cardiology, 78, 1996, pp. 34-40
HOW DO PHYSICIANS DETERMINE WHEN TO PERFORM AN ON-DRUG ELECTROPHYSIOLOGY STUDY FOR EFFICACY DETERMINATION IN PATIENTS WITH SUSTAINED VENTRICULAR TACHYARRHYTHMIAS - A PREVIOUSLY UNADDRESSED VARIABLE THAT MAY AFFECT EFFICACY RATES
Authors: REIFFEL JA BANKER J
Citation: Ja. Reiffel et J. Banker, HOW DO PHYSICIANS DETERMINE WHEN TO PERFORM AN ON-DRUG ELECTROPHYSIOLOGY STUDY FOR EFFICACY DETERMINATION IN PATIENTS WITH SUSTAINED VENTRICULAR TACHYARRHYTHMIAS - A PREVIOUSLY UNADDRESSED VARIABLE THAT MAY AFFECT EFFICACY RATES, PACE, 18(3), 1995, pp. 406-416
Risultati: 1-25 | 26-30